No takes yet. Share an insight, caveat, or question.
Review uncovers monocarboxylate transporter roles in cancer metabolism and signaling, highlighting their therapeutic potential as druggable targets.
Payen et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: